Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the month of September 2019, with a specific reporting date of September 4, 2019. The document serves as a regulatory notification under the EU Market Abuse Regulation regarding changes in the interests of Persons Discharging Managerial Responsibilities (PDMRs) due to awards made under the GSK Deferred Investment Award programme.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document is strictly a transaction notification regarding executive compensation.
Specific transaction details disclosed include:
- Instrument: Notional Ordinary Shares (ISIN: GB0009252882).
- Transaction Price: £17.434 per share.
- Transaction Volume: 10,050 shares per individual.
- Transaction Date: September 3, 2019.
Material Changes
The filing reports the initial notification of awards granted to two senior executives. There are no material changes to the company's financial position or operations reported in this document. The awards are subject to vesting conditions, specifically that the individuals must remain employed by GSK until the vesting date of February 13, 2022.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. The primary risk disclosed relates to the vesting conditions of the awards: they will not vest if the individuals serve notice of resignation or are terminated for cause. Additionally, the awards do not accrue dividends and will be settled in cash upon vesting rather than in physical shares.
Key Facts for Investor Verification
- Recipients: Ms. D. Conrad (SVP, Human Resources) and Ms. S. Jackson (SVP, Global Communication and CEO Office).
- Eligibility: Executive Directors are explicitly excluded from this specific Deferred Investment Award programme.
- Settlement Terms: Awards are notional shares paid in cash upon vesting; no dividends accrue during the vesting period.
- Historical Context: Both awards relate to employment prior to the individuals' appointment to GSK's Corporate Executive Team.